Table 3. p-values obtained on comparing the TMS parameters between the study groups.
| PDD vs | PDD vs | PDD vs | PD-MCI vs | PD-MCI | PD-nC | |
|---|---|---|---|---|---|---|
| PD-MCI | PD-nC | HC | PD-nC | vs HC | vs HC | |
| RMT | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| CMCT | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| cSP | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| iSP | 1.00 | 0.93 | 0.64 | 1.00 | 1.00 | 1.00 |
| SICI | 0.05 * | 0.00 ** | 0.00 ** | 0.01 * | 0.00 ** | 0.27 |
| ICF | 0.05 * | 0.00 ** | 0.00 ** | 0.05 * | 0.00 ** | 0.00 ** |
p < 0.05,
p < 0.01 (Tukey-HSD). CMCT: central motor conduction time, cSP: contralateral silent period, HC: healthy controls, ICF: intracortical facilitation, iSP: ipsilateral silent period, PD-nC: Parkinson’s disease without cognitive impairment, PDD: Parkinson’s disease with dementia, PD-MCI: Parkinson’s disease with mild cognitive impairment, RMT: resting motor threshold, SICI: short interval intracortical inhibition